Scott Requadt

2022

In 2022, Scott Requadt earned a total compensation of $4.3M as Former Chief Executive Officer and Former Director at Tourmaline Bio, a 481% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$191,210
Option Awards$3,253,600
Salary$580,000
Stock Awards$308,800
Other$12,200
Total$4,345,810

Requadt received $3.3M in option awards, accounting for 75% of the total pay in 2022.

Requadt also received $191.2K in non-equity incentive plan, $580K in salary, $308.8K in stock awards and $12.2K in other compensation.

Rankings

In 2022, Scott Requadt's compensation ranked 770th out of 5,753 executives tracked by ExecPay. In other words, Requadt earned more than 86.6% of executives.

ClassificationRankingPercentile
All
770
out of 5,753
87th
Division
Manufacturing
348
out of 3,133
89th
Major group
Chemicals And Allied Products
116
out of 1,419
92nd
Industry group
Drugs
103
out of 1,320
92nd
Industry
Biological Products, Except Diagnostic Substances
24
out of 291
92nd
Source: SEC filing on April 19, 2024.

Requadt's colleagues

We found two more compensation records of executives who worked with Scott Requadt at Tourmaline Bio in 2022.

2022

Michael Zdanowski

Tourmaline Bio

Chief Technology Officer

2022

Mary Fenton

Tourmaline Bio

Chief Executive Officer

News

In-depth

You may also like